GLP-1 therapies, or glucagon-like peptide-1 analogs , represent a substantial shift in how we handle type 2 diabetes . These new drugs help stimulating the body’s own GLP-1 substance , which encourages https://top100bookmark.com/story21874830/glp-1-a-major-approach-in-diabetes-treatment